Skip to Content Skip to Content

Medicine

Reset All Filters
1690 Results
Alzheimer’s drug trials target older Californians. Do they understand what they’re signing up for?

Alzheimer’s drug trials target older Californians. Do they understand what they’re signing up for?

Emily Largent of the Perelman School of Medicine supports the FDA’s recommendations that scientists running drug studies consider having an independent monitor such as a clinician unaffiliated with the trial’s sponsor oversee consent procedures. 

In Philly and nationwide, interest is rising in psychedelics to treat depression. The FDA released new research guidelines

In Philly and nationwide, interest is rising in psychedelics to treat depression. The FDA released new research guidelines

Holly Fernandez Lynch of the Perelman School of Medicine is quoted on the unique challenges of designing effective studies with psychedelic drugs, including participants knowing if they've been given a placebo or not.